Skip to main content
Erschienen in: Acta Neuropathologica 5/2016

26.07.2016 | Original Paper

The pathogenic relevance of αM-integrin in Guillain–Barré syndrome

verfasst von: Chaoling Dong, Steven P. Palladino, Eric Scott Helton, Eroboghene E. Ubogu

Erschienen in: Acta Neuropathologica | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The molecular determinants and mechanisms involved in leukocyte trafficking across the blood–nerve barrier (BNB) in the acute inflammatory demyelinating polyradiculoneuropathy (AIDP) variant of Guillain–Barré syndrome are incompletely understood. Prior work using a flow-dependent in vitro human BNB model demonstrated a crucial role for αM-integrin (CD11b)-intercellular adhesion molecule-1 interactions in AIDP patient leukocyte trafficking. The aim of this study is to directly investigate the biological relevance of CD11b in AIDP pathogenesis. Immunohistochemistry was performed on three AIDP patient sural nerve biopsies to evaluate endoneurial leukocyte CD11b expression. A severe murine experimental autoimmune neuritis (sm-EAN) model was utilized to determine the functional role of CD11b in leukocyte trafficking in vivo and determine its effect on neurobehavioral measures of disease severity, electrophysiological assessments of axonal integrity and myelination and histopathological measures of peripheral nerve inflammatory demyelination. Time-lapse video microscopy and electron microscopy were employed to observe structural alterations at the BNB during AIDP patient leukocyte trafficking in vitro and in situ, respectively. Large clusters of endoneurial CD11b+ leukocytes associated with demyelinating axons were observed in AIDP patient sural nerves. Leukocyte CD11b expression was upregulated during sm-EAN. 5 mg/kg of a function-neutralizing monoclonal rat anti-mouse CD11b antibody administered after sm-EAN disease onset significantly ameliorated disease severity, as well as electrophysiological and histopathological parameters of inflammatory demyelination compared to vehicle- and isotype antibody-treated mice. Consistent with in vitro observations of leukocyte trafficking at the BNB, electron micrographs of AIDP patient sural nerves demonstrated intact electron-dense endoneurial microvascular intercellular junctions during paracellular mononuclear leukocyte transmigration. Our data support a crucial pathogenic role of CD11b in AIDP leukocyte trafficking, providing a potential therapeutic target for demyelinating variants of Guillain–Barré syndrome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abe M, Sano Y, Maeda T, Shimizu F, Kashiwamura Y, Haruki H, Saito K, Tasaki A, Kawai M, Terasaki T, Kanda T (2012) Establishment and characterization of human peripheral nerve microvascular endothelial cell lines: a new in vitro blood–nerve barrier (BNB) model. Cell Struct Funct 37:89–100CrossRefPubMed Abe M, Sano Y, Maeda T, Shimizu F, Kashiwamura Y, Haruki H, Saito K, Tasaki A, Kawai M, Terasaki T, Kanda T (2012) Establishment and characterization of human peripheral nerve microvascular endothelial cell lines: a new in vitro blood–nerve barrier (BNB) model. Cell Struct Funct 37:89–100CrossRefPubMed
4.
Zurück zum Zitat Creange A, Chazaud B, Sharshar T, Plonquet A, Poron F, Eliezer MC, Raphael JC, Gherardi RK (2001) Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain–Barre syndrome associated with accumulation of proteolytically active lymphocytes in blood. J Neuroimmunol 114:188–196CrossRefPubMed Creange A, Chazaud B, Sharshar T, Plonquet A, Poron F, Eliezer MC, Raphael JC, Gherardi RK (2001) Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain–Barre syndrome associated with accumulation of proteolytically active lymphocytes in blood. J Neuroimmunol 114:188–196CrossRefPubMed
6.
7.
Zurück zum Zitat Greathouse KM, Palladino SP, Dong C, Helton ES, Ubogu EE (2016) Modeling leukocyte trafficking at the human blood–nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation. J Neuroinflam 13:3. doi:10.1186/s12974-015-0469-3 CrossRef Greathouse KM, Palladino SP, Dong C, Helton ES, Ubogu EE (2016) Modeling leukocyte trafficking at the human blood–nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation. J Neuroinflam 13:3. doi:10.​1186/​s12974-015-0469-3 CrossRef
8.
Zurück zum Zitat Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV, Plasma Exchange/Sandoglobulin Guillain–Barre Syndrome Trial G (2001) Preceding infections, immune factors, and outcome in Guillain–Barre syndrome. Neurology 56:758–765CrossRefPubMed Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV, Plasma Exchange/Sandoglobulin Guillain–Barre Syndrome Trial G (2001) Preceding infections, immune factors, and outcome in Guillain–Barre syndrome. Neurology 56:758–765CrossRefPubMed
10.
Zurück zum Zitat Kiefer R, Kieseier BC, Stoll G, Hartung HP (2001) The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64:109–127CrossRefPubMed Kiefer R, Kieseier BC, Stoll G, Hartung HP (2001) The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64:109–127CrossRefPubMed
11.
Zurück zum Zitat Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131–156. doi:10.1002/mus.20076 CrossRefPubMed Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131–156. doi:10.​1002/​mus.​20076 CrossRefPubMed
12.
Zurück zum Zitat Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP (2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125:823–834CrossRefPubMed Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP (2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125:823–834CrossRefPubMed
14.
Zurück zum Zitat zu Horste GM, Hartung HP, Kieseier BC (2007) From bench to bedside—experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat Clin Pract Neurol 3:198–211. doi:10.1038/ncpneuro0452 CrossRef zu Horste GM, Hartung HP, Kieseier BC (2007) From bench to bedside—experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat Clin Pract Neurol 3:198–211. doi:10.​1038/​ncpneuro0452 CrossRef
15.
Zurück zum Zitat Mizisin AP, Weerasuriya A (2011) Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol 121:291–312. doi:10.1007/s00401-010-0783-x CrossRefPubMed Mizisin AP, Weerasuriya A (2011) Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol 121:291–312. doi:10.​1007/​s00401-010-0783-x CrossRefPubMed
16.
Zurück zum Zitat Muller WA (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327–334PubMed Muller WA (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327–334PubMed
18.
Zurück zum Zitat Musso AM, Zanusso GL, Bonazzi ML, Tomelleri G, Bonetti B, Moretto G, Vio M, Monaco S (1994) Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system. Ital J Neurol Sci 15:267–271CrossRefPubMed Musso AM, Zanusso GL, Bonazzi ML, Tomelleri G, Bonetti B, Moretto G, Vio M, Monaco S (1994) Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system. Ital J Neurol Sci 15:267–271CrossRefPubMed
19.
Zurück zum Zitat Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphael JC, Gherardi RK, Creange A (2003) Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain–Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol 134:118–127CrossRefPubMed Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphael JC, Gherardi RK, Creange A (2003) Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain–Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol 134:118–127CrossRefPubMed
21.
Zurück zum Zitat Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF (2000) Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain–Barre syndrome. J Neurol Sci 174:16–21CrossRefPubMed Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF (2000) Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain–Barre syndrome. J Neurol Sci 174:16–21CrossRefPubMed
22.
Zurück zum Zitat Plasma Exchange/Sandoglobulin Guillain–Barre Syndrome Trial Group (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barre syndrome. Lancet 349:225–230CrossRef Plasma Exchange/Sandoglobulin Guillain–Barre Syndrome Trial Group (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barre syndrome. Lancet 349:225–230CrossRef
29.
35.
Zurück zum Zitat Xia RH, Yosef N, Ubogu EE (2010) Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data. Muscle Nerve 41:850–856. doi:10.1002/mus.21588 CrossRefPubMed Xia RH, Yosef N, Ubogu EE (2010) Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data. Muscle Nerve 41:850–856. doi:10.​1002/​mus.​21588 CrossRefPubMed
37.
Zurück zum Zitat Yosef N, Ubogu EE (2012) Alpha(M)beta(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain–Barre syndrome patient derived mononuclear leukocytes at the blood–nerve barrier in vitro. J Cell Physiol 227:3857–3875. doi:10.1002/jcp.24100 CrossRefPubMedPubMedCentral Yosef N, Ubogu EE (2012) Alpha(M)beta(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain–Barre syndrome patient derived mononuclear leukocytes at the blood–nerve barrier in vitro. J Cell Physiol 227:3857–3875. doi:10.​1002/​jcp.​24100 CrossRefPubMedPubMedCentral
Metadaten
Titel
The pathogenic relevance of αM-integrin in Guillain–Barré syndrome
verfasst von
Chaoling Dong
Steven P. Palladino
Eric Scott Helton
Eroboghene E. Ubogu
Publikationsdatum
26.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Acta Neuropathologica / Ausgabe 5/2016
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-016-1599-0

Weitere Artikel der Ausgabe 5/2016

Acta Neuropathologica 5/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.